Join Our Penny Stock Newsletter

Northwest Biotherapeutics, Inc. - NWBO

RSI %R Tweets Wolf Odds
51 -48 18 9.76%

Industry: Biotechnology / Sector: Healthcare

NWBO Chart

NWBO Quote

Prev Close: 0.3211
Open: 0.3251
Last Trade: 0.325765
Change %: +1.450%
Change: +0.0046650
Volume: 534645
Avg Vol: 1978722
Relative Vol: 0.27
Day Range: 0.32 -0.3259
52-Week Range: 0.1400 - 0.9800
Market Cap: 50.28M
Float: 249.83M
Shares Outstanding: 315.12M
Insider Owned: 5.81%
Institution Owned: 18.92%
Beta: 2.61
PE Ratio: 0.00
EPS: -0.3940

NWBO Detailed Stats

RSI:51.44 %K:52.05 Wolf Odds: 9.76% Tweets Today:18 SMA14:0.3283
stochRSI:0.53 %D:51.76 Wolf Trend:0.47 Tweet Avg:24 Pivot Price:0.3238883
%R:-47.95 %B:0.42 Wolf 3-Day:0.45 Avg. Change 3-Day:+0.840% Resistance 1:0.3277767
MFI:55.82 Bandwidth:0.090473 Wolf 7-Day:0.42 Avg. Change 7-Day:-0.379% Resistance 2:0.3297883
WolfPeak:0.51 Vortex Indicator:0.06 Wolf 14-Day:0.53 Avg. Change 14-Day:+0.35% Support 1:0.3218767
ROC 7/14:-2.7567/3.4175 Aroon Oscillator:28.5714 EOM:-0.001154 Relative Vol:0.27 Support 2:0.3179883
RSI Alert:None WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:None

Featured News *


    NWBO Description

    Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient?s own immune system to attack cancer. It is developing DCVax-L, a product in Phase III clinical trials to treat Glioblastome multiforme, a brain cancer; and DCVax-Direct, a product in Phase I/II clinical trials to treat various types of inoperable solid tumor cancers. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

    NWBO Comments

    Recent NWBO Tweets

    Powered by Ekonomys ver. 9

    StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

    30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell


    Stock Wolf Twitter

    Stock Wolf Facebook